Abstract

Recent advances in prostate cancer surgery have significantly improved the accuracy of tumor identification, realtime diagnosis, and resection precision through the use of prostate-specific membrane antigen (PSMA) targeting. This paper explores the latest developments in PSMA-targeted surgical techniques, highlighting their impact on enhancing the precision of prostate cancer management. PSMA-targeted imaging and surgical guidance allow for more accurate localization of cancerous tissues, enabling real-time diagnosis and more precise resection of tumors. The paper discusses various PSMA-targeted approaches, including imaging modalities and surgical tools, and their integration into clinical practice. By examining current evidence and future prospects, this study aims to provide a comprehensive overview of how PSMA targeting is advancing prostate cancer surgery and improving patient outcomes.